MK-0159
oral CD38 inhibitor in vivo efficacy in a murine model of cardiac I/R from the previously disclosed inhibitor CD38i J. Med. Chem. Mitobridge (an Astellas Company), Cambridge, MA
Molecules of the Month - June 2022
oral CD38 inhibitor in vivo efficacy in a murine model of cardiac I/R from the previously disclosed inhibitor CD38i J. Med. Chem. Mitobridge (an Astellas Company), Cambridge, MA
Molecules of the Month - June 2022